User profiles for Tom De Bruyn

Tom De Bruyn

Senior Principal Scientist at Genentech
Verified email at gene.com
Cited by 998

[PDF][PDF] Therapeutic ligands antagonize estrogen receptor function by impairing its mobility

…, M Hafner, RA Blake, C Chalouni, IP Chen, T De Bruyn… - Cell, 2019 - cell.com
Estrogen receptor-positive (ER + ) breast cancers frequently remain dependent on ER
signaling even after acquiring resistance to endocrine agents, prompting the development of …

Structure-based identification of OATP1B1/3 inhibitors

T De Bruyn, GJP Van Westen, AP IJzerman… - Molecular …, 2013 - ASPET
Several recent studies show that inhibition of the hepatic transport proteins organic anion-transporting
polypeptide 1B1 (OATP1B1) and 1B3 (OATP1B3) can result in clinically relevant …

Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity

T De Bruyn, S Chatterjee, S Fattah… - Expert opinion on …, 2013 - Taylor & Francis
Introduction: The sandwich-cultured hepatocyte (SCH) model has become an invaluable in
vitro tool for studying hepatic drug transport, metabolism, biliary excretion and toxicity. The …

Disruption of IRE1α through its kinase domain attenuates multiple myeloma

…, M Lorenzo, J Wu, J Ly, T De Bruyn… - Proceedings of the …, 2019 - National Acad Sciences
Multiple myeloma (MM) arises from malignant immunoglobulin (Ig)-secreting plasma cells
and remains an incurable, often lethal disease despite therapeutic advances. The unfolded-…

[BOOK][B] Dynamics of remittance utilization in Bangladesh

T De Bruyn, U Kuddus… - 2005 - researchgate.net
Tom De Bruyn (Tom De Bruyn is a geographer and development planner. He is currently …
Tom De Bruyn has prepared this article on the occasion of BASUG’s forum on “Remittances …

Latest generation estrogen receptor degraders for the treatment of hormone receptor-positive breast cancer

YC Chen, J Yu, C Metcalfe, T De Bruyn… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction The selective estrogen receptor degrader (SERD) and full receptor antagonist
provides an important therapeutic option for hormone receptor (HR)-positive breast cancer. …

The emergence of a fourth pillar in development aid

P Develtere, T De Bruyn - Development in practice, 2009 - Taylor & Francis
Development co-operation has traditionally been the playing field of governments, multilateral
institutions, and established development NGOs. In the past decade, however, other …

Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3

T De Bruyn, S Fattah, B Stieger, P Augustijns… - Journal of …, 2011 - Elsevier
… a single pool of human hepatocytes measured in this study or previously by De Bruyn et al.
Tom De Bruyn received a PhD scholarship from the Agency for Innovation by Science and …

Predicting human clearance of organic anion transporting polypeptide substrates using cynomolgus monkey: in vitro–in vivo scaling of hepatic uptake clearance

T De Bruyn, A Ufuk, C Cantrill, RE Kosa, Y Bi… - Drug Metabolism and …, 2018 - ASPET
This work explores the utility of the cynomolgus monkey as a preclinical model to predict
hepatic uptake clearance mediated by organic anion transporting polypeptide (OATP) …

Exploring food effects on indinavir absorption with human intestinal fluids in the mouse intestine

N Holmstock, T De Bruyn, J Bevernage… - European Journal of …, 2013 - Elsevier
Food can have a significant impact on the pharmacokinetics of orally administered drugs, as
it may affect drug solubility as well as permeability. Since fed state conditions cannot easily …